+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07445334

Comparing Catheter Ablation and Anti-arrhythmic Drugs for Treating Premature Ventricular Complexes A Randomized Controlled Trial

Led by Western Sydney Local Health District · Updated on 2026-09-24

50

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing catheter ablation and medication treatments for premature ventricular complexes PVCs, a common type of abnormal heartbeat originating from the hearts ventricles. This study aims to determine which approach better reduces symptoms and improves quality of life for patients with PVCs. The trial focuses on adult participants with significant PVC burden and normal heart function. Participants are randomly assigned to either undergo catheter ablation or receive medical therapy. Those in the catheter ablation group will have the procedure within two weeks of randomization, guided by advanced mapping techniques to target the PVCs. Medical therapy participants will be treated with anti-arrhythmic drugs or beta-blockers, with recommended starting doses and adjustments based on tolerance and physician discretion. During the 12-week study period, participants will be closely monitored through heart rhythm assessments and quality-of-life questionnaires at baseline, six weeks, and twelve weeks after randomization. Researchers will measure reductions in PVC burden, treatment tolerability, and health service use. The primary outcome focuses on the proportion of participants achieving at least an 80% reduction in PVCs over 12 weeks.

CONDITIONS

Brief Title

Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes

Research Team

S

Saurabh Kumar, MBBS, PhD

S

Sam Turnbull

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here